DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jemnitz, K.
Right arrow Articles by Vereczkey, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jemnitz, K.
Right arrow Articles by Vereczkey, L.

Vol. 28, Issue 1, 34-37, January 2000

Glucuronidation of Thyroxine in Primary Monolayer Cultures of Rat Hepatocytes: In Vitro Induction of UDP-Glucuronosyltranferases by Methylcholanthrene, Clofibrate, and Dexamethasone Alone and in Combination

Katalin Jemnitz, Zsuzsa Veres, Katalin Monostory, and László Vereczkey

Institute of Chemistry Chemical Research Center, Hungarian Academy of Sciences, Budapest, Hungary

Induction of UDP-glucuronosyltransferases (UGTs) toward thyroxine (T4) and p-nitrophenol (pNP) by 3-methylcholanthrene (MC), dexamethasone (DEX), clofibrate (Cl), and MC combined with DEX or Cl was studied in rat hepatocyte culture. We have developed a sensitive method for the measurement of glucuronide conjugates of the two substrates based on HPLC analysis of culture medium. MC, Cl, or DEX increased the activity of T4 UGT. Combination of MC and Cl showed additive effect, enzyme activity was enhanced compared with either MC or Cl treatment alone (617, 441, and 217% of the control, respectively). Combination of MC and DEX did not result in higher T4 UGT activity than MC treatment alone. Both MC and DEX enhanced the pNP UGT activity (182 and 162% of the control, respectively). Combination of MC with DEX resulted in additive effect. Cl treatment did not affect pNP conjugation either alone or in combination with MC. Western blot analysis revealed that only the amount of UGT1A1 was elevated by Cl and DEX. In contrast, concentration of UGT1A6 was increased by MC. Previous studies demonstrated that UGT1A1 inducers like phenobarbital have no effect on T4 conjugation (Saito et al., 1991). Our results suggest that Cl, a known inducer of UGT1A1, enhances the activity of other enzyme(s) involved in T4 glucuronidation as well. It is well documented that DEX potentiates the inductory effect of polycyclic aromatic hydrocarbon on UGT1A6 (Xiao et al., 1995). In our study, MC increased the rate of T4 glucuronidation, and DEX had no additional effect on this reaction, suggesting that UGT1A6 is not the only enzyme inducible by MC that can catalyze T4 conjugation.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
EndocrinologyHome page
Y. Emi, S.-i. Ikushiro, and Y. Kato
Thyroxine-Metabolizing Rat Uridine Diphosphate-Glucuronosyltransferase 1A7 Is Regulated by Thyroid Hormone Receptor
Endocrinology, December 1, 2007; 148(12): 6124 - 6133.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Luci, H. Kluge, F. Hirche, and K. Eder
Clofibrate Increases Hepatic Triiodothyronine (T3)- and Thyroxine (T4)-Glucuronosyltransferase Activities and Lowers Plasma T3 and T4 Concentrations in Pigs
Drug Metab. Dispos., November 1, 2006; 34(11): 1887 - 1892.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
G. Werle-Schneider, A. Wolfelschneider, M. C. von Brevern, J. Scheel, T. Storck, D. Muller, R. Glockner, H. Bartsch, and M. Bartelmann
Gene Expression Profiles in Rat Liver Slices Exposed to Hepatocarcinogenic Enzyme Inducers, Peroxisome Proliferators, and 17{alpha}-Ethinylestradiol
International Journal of Toxicology, September 1, 2006; 25(5): 379 - 395.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
N. Nishimura, J. Yonemoto, H. Nishimura, S.-i. Ikushiro, and C. Tohyama
Disruption of Thyroid Hormone Homeostasis at Weaning of Holtzman Rats by Lactational but Not In Utero Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
Toxicol. Sci., May 1, 2005; 85(1): 607 - 614.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. Nie, S. Sweetser, M. Rinella, and R. M. Green
Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-{alpha} and -{gamma}
Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G207 - G212.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
F. de Longueville, F. A. Atienzar, L. Marcq, S. Dufrane, S. Evrard, L. Wouters, F. Leroux, V. Bertholet, B. Gerin, R. Whomsley, et al.
Use of a Low-Density Microarray for Studying Gene Expression Patterns Induced by Hepatotoxicants on Primary Cultures of Rat Hepatocytes
Toxicol. Sci., October 1, 2003; 75(2): 378 - 392.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Barbier, D. Duran-Sandoval, I. Pineda-Torra, V. Kosykh, J.-C. Fruchart, and B. Staels
Peroxisome Proliferator-activated Receptor {alpha} Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme
J. Biol. Chem., August 29, 2003; 278(35): 32852 - 32860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Barbier, L. Villeneuve, V. Bocher, C. Fontaine, I. P. Torra, C. Duhem, V. Kosykh, J.-C. Fruchart, C. Guillemette, and B. Staels
The UDP-glucuronosyltransferase 1A9 Enzyme Is a Peroxisome Proliferator-activated Receptor alpha and gamma Target Gene
J. Biol. Chem., April 11, 2003; 278(16): 13975 - 13983.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.